We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.91B
AUM Growth
-$58.7M
Cap. Flow
-$6.54M
Cap. Flow %
-0.34%
Top 10 Hldgs %
39.91%
Holding
252
New
15
Increased
80
Reduced
73
Closed
17

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$5.48M
2
MS icon
Morgan Stanley
MS
+$5.37M
3
PFE icon
Pfizer
PFE
+$4.76M
4
FAST icon
Fastenal
FAST
+$4.66M
5
TGT icon
Target
TGT
+$4.36M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.8M
3
DIS icon
Walt Disney
DIS
+$8.48M
4
LMT icon
Lockheed Martin
LMT
+$6.84M
5
TRV icon
Travelers Companies
TRV
+$3.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.07%
2 Technology 21.25%
3 Healthcare 12.53%
4 Financials 11.18%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
76
PayPal
PYPL
$49.6B
$6.58M 0.35%
56,897
-340
-0.6% -$45.2K
STZ icon
77
Constellation Brands
STZ
$22.3B
$6.52M 0.34%
28,307
+168
+0.6% +$38.8K
SCHW
78
Charles Schwab
SCHW
$188B
$6.11M 0.32%
72,450
-8,098
-10% -$712K
QCOM icon
79
Qualcomm
QCOM
$165B
$5.89M 0.31%
38,539
+7,934
+26% +$1.33M
WST icon
80
West Pharmaceutical
WST
$24.7B
$5.75M 0.3%
+14,000
New +$5.48M
MMM icon
81
3M
MMM
$93.9B
$5.66M 0.3%
45,496
-10,904
-19% -$1.45M
BBY icon
82
Best Buy
BBY
$17.8B
$5.5M 0.29%
60,450
+16,337
+37% +$1.62M
ITW icon
83
Illinois Tool Works
ITW
$85.5B
$5.47M 0.29%
26,144
-480
-2% -$107K
CERN
84
DELISTED
Cerner Corp
CERN
$5.43M 0.28%
58,020
-27,500
-32% -$2.55M
AEP icon
85
American Electric Power
AEP
$68.8B
$5.38M 0.28%
53,975
-300
-0.6% -$27.4K
MS icon
86
Morgan Stanley
MS
$343B
$5.3M 0.28%
60,666
+55,625
+1,103% +$5.37M
V icon
87
Visa
V
$688B
$5.22M 0.27%
23,534
+200
+0.9% +$43.3K
LRCX icon
88
Lam Research
LRCX
$385B
$5.21M 0.27%
97,000
CHRW icon
89
C.H. Robinson
CHRW
$17.9B
$4.99M 0.26%
46,326
+2,645
+6% +$269K
MNST icon
90
Monster Beverage
MNST
$92.4B
$4.91M 0.26%
122,800
-6,800
-5% -$285K
KLAC icon
91
KLA
KLAC
$252B
$4.78M 0.25%
130,600
+20,800
+19% +$778K
PLD icon
92
Prologis
PLD
$131B
$4.61M 0.24%
28,557
+3,884
+16% +$593K
DOW icon
93
Dow Inc
DOW
$21.4B
$4.48M 0.24%
70,369
-2,547
-3% -$154K
LMT icon
94
Lockheed Martin
LMT
$133B
$4.43M 0.23%
10,044
-16,876
-63% -$6.84M
BAC icon
95
Bank of America
BAC
$442B
$4.43M 0.23%
107,405
+2,341
+2% +$106K
META icon
96
Meta Platforms (Facebook)
META
$1.5T
$4.41M 0.23%
19,832
-8,403
-30% -$2.1M
IP icon
97
International Paper
IP
$22.4B
$4.37M 0.23%
94,688
+8,074
+9% +$372K
MRK icon
98
Merck
MRK
$317B
$4.26M 0.22%
51,983
+9,460
+22% +$746K
MA icon
99
Mastercard
MA
$500B
$4.23M 0.22%
11,840
+2,050
+21% +$737K
SPG icon
100
Simon Property Group
SPG
$72.9B
$4.2M 0.22%
31,955
-3,800
-11% -$541K

Similar funds

Cullinan Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Cullinan Associates held 252 positions worth $1.91B, down 3% from $1.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q1 2022 filing shows 15 new, 80 increased, 73 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 14,000 shares worth $5.75M. The largest sale was Walmart Inc, an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q1 2022 buy was West Pharmaceutical: 14,000 shares worth $5.75M.
  • Cullinan Associates added most to Morgan Stanley in Q1 2022, an estimated $5.37M increase.
  • Cullinan Associates's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Vontier in Q1 2022, selling an estimated $758K.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.91B portfolio in Q1 2022.
  • Cullinan Associates opened 15 new positions and closed 17 in Q1 2022.
  • Cullinan Associates's portfolio value fell 3% quarter-over-quarter to $1.91B.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.